N-glycoprotein macroheterogeneity: biological implications and proteomic characterization

Glycoconjugate Journal

Volumn 33, Issue 3, 2016, Pages 359-376

  Zacchi, Lucia F ^a,b   Schulz, Benjamin L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

Glycoprotein; Glycoproteomics; Glycosylation; Macroheterogeneity; Mass spectrometry

Indexed keywords

ANTIBODY; GLYCOPEPTIDE; GLYCOPROTEIN; GLYCOPROTEIN HORMONE; HORMONE; N GLYCOPROTEIN; O GLYCOPEPTIDE; RIBONUCLEASE; UNCLASSIFIED DRUG; PROTEOME;

ARTICLE; BIOTECHNOLOGY; CONGENITAL DISORDER OF GLYCOSYLATION; DEGLYCOSYLATION; ENZYME ACTIVITY; EVOLUTION; FIBRINOLYSIS; GENETIC ANALYSIS; GLYCOENGINEERING; GLYCOSYLATION; HUMAN; MASS SPECTROMETRY; NONHUMAN; PHYSIOLOGY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN MACROHETEROGENEITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEOMICS; QUALITY CONTROL; STOICHIOMETRY; ANIMAL; CHEMISTRY; CLASSIFICATION; METABOLISM; PROCEDURES; PROTEIN PROCESSING;

ANIMALS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME;

EID: 84952940199     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-015-9641-3     Document Type: Article

References (182)

1. Helenius, A., Aebi, M.: Intracellular functions of N-linked glycans. Science (New York, N.Y.) 291(5512), 2364–2369 (2001)
2. Aebi, M.: N-linked protein glycosylation in the ER. Biochim. Biophys. Acta 1833(11), 2430–2437 (2013). doi:10.1016/j.bbamcr.2013.04.001
3. Abu-Qarn, M., Eichler, J., Sharon, N.: Not just for Eukarya anymore: protein glycosylation in Bacteria and Archaea. Curr. Opin. Struct. Biol. 18(5), 544–550 (2008). doi:10.1016/j.sbi.2008.06.010
4. Spiro, R.G.: Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12(4), 43R–56R (2002)
5. Wopereis, S., Lefeber, D.J., Morava, E., Wevers, R.A.: Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. Clin. Chem. 52(4), 574–600 (2006). doi:10.1373/clinchem.2005.063040
6. Gupta, R., Birch, H., Rapacki, K., Brunak, S., Hansen, J.E.: O-GLYCBASE version 4.0: a revised database of O-glycosylated proteins. Nucleic Acids Res. 27(1), 370–372 (1999)
7. Tran, D.T., Ten Hagen, K.G.: Mucin-type O-glycosylation during development. J. Biol. Chem. 288(10), 6921–6929 (2013). doi:10.1074/jbc.R112.418558
8. Lommel, M., Strahl, S.: Protein O-mannosylation: conserved from bacteria to humans. Glycobiology 19(8), 816–828 (2009). doi:10.1093/glycob/cwp066
9. Goto, M.: Protein O-glycosylation in fungi: diverse structures and multiple functions. Biosci. Biotechnol. Biochem. 71(6), 1415–1427 (2007). doi:10.1271/bbb.70080
10. Bond, M.R., Hanover, J.A.: A little sugar goes a long way: the cell biology of O-GlcNAc. J. Cell Biol. 208(7), 869–880 (2015). doi:10.1083/jcb.201501101
11. Sakaidani, Y., Nomura, T., Matsuura, A., Ito, M., Suzuki, E., Murakami, K., Nadano, D., Matsuda, T., Furukawa, K., Okajima, T.: O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions. Nat. Commun. 2, 583 (2011). doi:10.1038/ncomms1591
12. Cylwik, B., Lipartowska, K., Chrostek, L., Gruszewska, E.: Congenital disorders of glycosylation. part II. defects of protein O-glycosylation. Acta Biochim. Pol. 60(3), 361–368 (2013)
13. Kelleher, D.J., Gilmore, R.: An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology 16(4), 47R–62R (2006)
14. Schulz, B.L.: Beyond the sequon: sites of N-glycosylation. In: Petrescu, S. (ed.) Glycosylation, pp. 21–40. Intech, Rijeka (2012)
15. Lizak, C., Gerber, S., Numao, S., Aebi, M., Locher, K.P.: X-ray structure of a bacterial oligosaccharyltransferase. Nature 474(7351), 350–355 (2011)
16. Jones, J., Krag, S.S., Betenbaugh, M.J.: Controlling N-linked glycan site occupancy. Biochim. Biophys. Acta 1726(2), 121–137 (2005). doi:10.1016/j.bbagen.2005.07.003
17. Zielinska, D.F., Gnad, F., Wisniewski, J.R., Mann, M.: Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141(5), 897–907 (2010)
18. Ruiz-Canada, C., Kelleher, D.J., Gilmore, R.: Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 136(2), 272–283 (2009)
19. Nasab, F.P., Schulz, B.L., Gamarro, F., Parodi, A.J., Aebi, M.: All in one: leishmania major STT3 proteins substitute for the whole oligosaccharyltransferase complex in Saccharomyces cerevisiae. Mol. Biol. Cell 19(9), 3758–3768 (2008). doi:10.1091/mbc.E08-05-0467
20. Izquierdo, L., Mehlert, A., Ferguson, M.A.: The lipid-linked oligosaccharide donor specificities of Trypanosoma brucei oligosaccharyltransferases. Glycobiology 22(5), 696–703 (2012)
21. Izquierdo, L., Schulz, B.L., Rodrigues, J.A., Güther, M.L., Procter, J.B., Barton, G.J., Aebi, M., Ferguson, M.A.: Distinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases. EMBO J. 28(17), 2650–2661 (2009)
22. Schulz, B.L., Stirnimann, C.U., Grimshaw, J.P.A., Brozzo, M.S., Fritsch, F., Mohorko, E., Capitani, G., Glockshuber, R., Grütter, M.G., Aebi, M.: Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency. Proc. Natl. Acad. Sci. U. S. A. 106(27), 11061–11066 (2009)
23. Jamaluddin, M.F.B., Bailey, U.M., Tan, N.Y.J., Stark, A.P., Schulz, B.L.: Polypeptide binding specificities of Saccharomyces cerevisiae oligosaccharyltransferase accessory proteins Ost3p and Ost6p. Protein Sci. 20(5), 849–855 (2011). doi:10.1002/pro.610
24. Mohd Yusuf, S.N., Bailey, U.M., Tan, N.Y.J., Jamaluddin, M.F.B., Schulz, B.L.: Mixed disulfide formation in vitro between a glycoprotein substrate and yeast oligosaccharyltransferase subunits Ost3p and Ost6p. Biochem. Biophys. Res. Commun. 432(3), 438–443 (2013). doi:10.1016/j.bbrc.2013.01.128
25. Cherepanova, N.A., Shrimal, S., Gilmore, R.: Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J. Cell Biol. 206(4), 525–539 (2014). doi:10.1083/jcb.201404083
26. Jamaluddin, M.F., Bailey, U.M., Schulz, B.L.: Oligosaccharyltransferase subunits bind polypeptide substrate to locally enhance N-glycosylation. Mol. Cell. Proteomics 13(12), 3286–3293 (2014). doi:10.1074/mcp.M114.041178
27. Schwarz, M., Knauer, M., Lehle, L.: Yeast oligosaccharyltransferase consists of two functionally distinct sub-complexes, specified by either the Ost3p or Ost6p subunit. FEBS Lett. 579(29), 6564–6568 (2005)
28. Spirig, U., Bodmer, D., Wacker, M., Burda, P., Aebi, M.: The 3.4-kDa Ost4 protein is required for the assembly of two distinct oligosaccharyltransferase complexes in yeast. Glycobiology 15(12), 1396–1406 (2005)
29. Karaoglu, D., Kelleher, D.J., Gilmore, R.: Functional characterization of Ost3p. loss of the 34-kD subunit of the Saccharomyces cerevisiae oligosaccharyltransferase results in biased underglycosylation of acceptor substrates. J. Cell Biol. 130(3), 567–577 (1995)
30. Schulz, B.L., Aebi, M.: Analysis of glycosylation site occupancy reveals a role for Ost3p and Ost6p in site-specific N-glycosylation efficiency. Mol. Cell. Proteomics 8(2), 357–364 (2009). doi:10.1074/mcp.M800219-MCP200
31. Shrimal, S., Trueman, S.F., Gilmore, R.: Extreme C-terminal sites are posttranslocationally glycosylated by the STT3B isoform of the OST. J. Cell Biol. 201(1), 81–95 (2013). doi:10.1083/jcb.201301031
32. Shrimal, S., Gilmore, R.: Glycosylation of closely spaced acceptor sites in human glycoproteins. J. Cell Sci. 126(Pt 23), 5513–5523 (2013). doi:10.1242/jcs.139584
33. Mohorko, E., Owen, R.L., Malojcic, G., Brozzo, M.S., Aebi, M., Glockshuber, R.: Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation. Structure (London, England: 1993) 22(4), 590–601 (2014). doi:10.1016/j.str.2014.02.013
34. Bause, E.: Structural requirements of N-glycosylation of proteins. studies with proline peptides as conformational probes. Biochem. J. 209(2), 331–336 (1983)
35. Mellquist, J.L., Kasturi, L., Spitalnik, S.L., Shakin-Eshleman, S.H.: The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry 37(19), 6833–6837 (1998). doi:10.1021/bi972217k
36. Becchis, M., Frairia, R., Ferrera, P., Fazzari, A., Ondei, S., Alfarano, A., Coluccia, C., Biglia, N., Sismondi, P., Fortunati, N.: The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer. Breast Cancer Res. Treat. 54(2), 101–107 (1999)
37. Deshpande, K.L., Fried, V.A., Ando, M., Webster, R.G.: Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. U. S. A. 84(1), 36–40 (1987)
38. Tate, M.D., Job, E.R., Deng, Y.M., Gunalan, V., Maurer-Stroh, S., Reading, P.C.: Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 6(3), 1294–1316 (2014). doi:10.3390/v6031294
39. Rao, R.S., Wollenweber, B.: Subtle evolutionary changes in the distribution of N-glycosylation sequons in the HIV-1 envelope glycoprotein 120. Int. J. Biol. Sci. 6(5), 407–418 (2010)
40. Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., Komarova, N.L., Nowak, M.A., Hahn, B.H., Kwong, P.D., Shaw, G.M.: Antibody neutralization and escape by HIV-1. Nature 422(6929), 307–312 (2003). doi:10.1038/nature01470
41. Montefiori, D.C., Robinson Jr., W.E., Mitchell, W.M.: Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 85(23), 9248–9252 (1988)
42. Mascola, J.R., Montefiori, D.C.: HIV-1: nature’s master of disguise. Nat. Med. 9(4), 393–394 (2003). doi:10.1038/nm0403-393
43. Horiya, S., MacPherson, I.S., Krauss, I.J.: Recent strategies targeting HIV glycans in vaccine design. Nat. Chem. Biol. 10(12), 990–999 (2014). doi:10.1038/nchembio.1685
44. Ragni, E., Fontaine, T., Gissi, C., Latgè, J.P., Popolo, L.: The Gas family of proteins of Saccharomyces cerevisiae: characterization and evolutionary analysis. Yeast 24(4), 297–308 (2007)
45. Ragni, E., Coluccio, A., Rolli, E., Rodriguez-Pena, J.M., Colasante, G., Arroyo, J., Neiman, A.M., Popolo, L.: GAS2 and GAS4, a pair of developmentally regulated genes required for spore wall assembly in Saccharomyces cerevisiae. Eukaryot. Cell 6(2), 302–316 (2007). doi:10.1128/ec.00321-06
46. Tan, N.Y., Bailey, U.M., Jamaluddin, M.F., Mahmud, S.H., Raman, S.C., Schulz, B.L.: Sequence-based protein stabilization in the absence of glycosylation. Nat. Commun. 5, 3099 (2014). doi:10.1038/ncomms4099
47. Burda, P., Aebi, M.: The dolichol pathway of N-linked glycosylation. Biochim. Biophys. Acta 1426(2), 239–257 (1999)
48. Freeze, H.H., Chong, J.X., Bamshad, M.J., Ng, B.G.: Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 94(2), 161–175 (2014)
49. Hauri, H.P., Nufer, O., Breuza, L., Tekaya, H.B., Liang, L.: Lectins and protein traffic early in the secretory pathway. Biochem. Soc. Symp. (69), 73–82 (2002)
50. Bosques, C.J., Tschampel, S.M., Woods, R.J., Imperiali, B.: Effects of glycosylation on peptide conformation: a synergistic experimental and computational study. J. Am. Chem. Soc. 126(27), 8421–8425 (2004). doi:10.1021/ja0496266
51. Vagin, O., Kraut, J.A., Sachs, G.: Role of N-glycosylation in trafficking of apical membrane proteins in epithelia. Am. J. Physiol. Renal Physiol. 296(3), F459–469 (2009). doi:10.1152/ajprenal.90340.2008
52. Caramelo, J.J., Parodi, A.J.: A sweet code for glycoprotein folding. FEBS Lett. (2015). doi:10.1016/j.febslet.2015.07.021
53. Zacchi, L.F., Caramelo, J.J., McCracken, A.A., Brodsky, J.L.: Endoplasmic reticulum associated degradation and protein quality control. In: Stahl, R.B.P. (ed.) The encyclopedia of cell biology, vol. 1, pp. 596–611. Academic, Waltham (2016)
54. Hebert, D.N., Zhang, J.X., Chen, W., Foellmer, B., Helenius, A.: The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 139(3), 613–623 (1997)
55. Zacchi, L.F., Wu, H.C., Bell, S.L., Millen, L., Paton, A.W., Paton, J.C., Thomas, P.J., Zolkiewski, M., Brodsky, J.L.: The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia. J. Biol. Chem. 289(18), 12727–12747 (2014). doi:10.1074/jbc.M113.529123
56. Bragg, D.C., Kaufman, C.A., Kock, N., Breakefield, X.O.: Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA. Mol. Cell. Neurosci. 27(4), 417–426 (2004)
57. Kostova, Z., Wolf, D.H.: Importance of carbohydrate positioning in the recognition of mutated CPY for ER-associated degradation. J. Cell Sci. 118(Pt 7), 1485–1492 (2005). doi:10.1242/jcs.01740
58. Spear, E.D., Ng, D.T.: Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation. J. Cell Biol. 169(1), 73–82 (2005). doi:10.1083/jcb.200411136
59. Xie, W., Kanehara, K., Sayeed, A., Ng, D.T.: Intrinsic conformational determinants signal protein misfolding to the Hrd1/Htm1 endoplasmic reticulum-associated degradation system. Mol. Biol. Cell 20(14), 3317–3329 (2009). doi:10.1091/mbc.E09-03-0231
60. Bousfield, G.R., Dias, J.A.: Synthesis and secretion of gonadotropins including structure-function correlates. Rev. Endocr. Metab. Disord. 12(4), 289–302 (2011). doi:10.1007/s11154-011-9191-3
61. Ulloa-Aguirre, A., Timossi, C., Damian-Matsumura, P., Dias, J.A.: Role of glycosylation in function of follicle-stimulating hormone. Endocrine 11(3), 205–215 (1999). doi:10.1385/endo:11:3:205
62. Bousfield, G.R., Butnev, V.Y., Walton, W.J., Nguyen, V.T., Huneidi, J., Singh, V., Kolli, V.S., Harvey, D.J., Rance, N.E.: All-or-none N-glycosylation in primate follicle-stimulating hormone beta-subunits. Mol. Cell. Endocrinol. 260–262, 40–48 (2007). doi:10.1016/j.mce.2006.02.017
63. Bousfield, G.R., Butnev, V.Y., Rueda-Santos, M.A., Brown, A., Hall, A.S., Harvey, D.J.: Macro- and micro-heterogeneity in pituitary and urinary follicle-stimulating hormone glycosylation. J. Glycom. Lipidom. 4 (2014). doi: 10.4172/2153-0637.1000125
64. Wide, L., Eriksson, K.: Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation. Ups. J. Med. Sci. 118(3), 153–164 (2013). doi:10.3109/03009734.2013.782081
65. Valove, F.M., Finch, C., Anasti, J.N., Froehlich, J., Flack, M.R.: Receptor binding and signal transduction are dissociable functions requiring different sites on follicle-stimulating hormone. Endocrinology 135(6), 2657–2661 (1994). doi:10.1210/endo.135.6.7988456
66. Matzuk, M.M., Keene, J.L., Boime, I.: Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction. J. Biol. Chem. 264(5), 2409–2414 (1989)
67. Sumer-Bayraktar, Z., Nguyen-Khuong, T., Jayo, R., Chen, D.D., Ali, S., Packer, N.H., Thaysen-Andersen, M.: Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serum. Proteomics 12(22), 3315–3327 (2012)
68. Simo, R., Saez-Lopez, C., Barbosa-Desongles, A., Hernandez, C., Selva, D.M.: Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab.: TEM 26(7), 376–383 (2015). doi:10.1016/j.tem.2015.05.001
69. Bocchinfuso, W.P., Ma, K.L., Lee, W.M., Warmels-Rodenhiser, S., Hammond, G.L.: Selective removal of glycosylation sites from sex hormone-binding globulin by site-directed mutagenesis. Endocrinology 131(5), 2331–2336 (1992). doi:10.1210/endo.131.5.1425432
70. Raineri, M., Catalano, M.G., Hammond, G.L., Avvakumov, G.V., Frairia, R., Fortunati, N.: O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation. Mol. Cell. Endocrinol. 189(1–2), 135–143 (2002)
71. Ng, K.M., Catalano, M.G., Pinos, T., Selva, D.M., Avvakumov, G.V., Munell, F., Hammond, G.L.: Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin. J. Biol. Chem. 281(23), 15853–15861 (2006). doi:10.1074/jbc.M512370200
72. Hong, E.J., Sahu, B., Janne, O.A., Hammond, G.L.: Cytoplasmic accumulation of incompletely glycosylated SHBG enhances androgen action in proximal tubule epithelial cells. Molec. Endocrinol (Baltimore, Md.) 25(2), 269–281 (2011). doi:10.1210/me.2010-0483
73. Cousin, P., Dechaud, H., Grenot, C., Lejeune, H., Hammond, G.L., Pugeat, M.: Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood. J. Steroid Biochem. Molec. Biol. 70(4–6), 115–121 (1999)
74. Rudd, P.M., Woods, R.J., Wormald, M.R., Opdenakker, G., Downing, A.K., Campbell, I.D., Dwek, R.A.: The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator. Biochim. Biophys. Acta 1248(1), 1–10 (1995)
75. Pohl, G., Kallstrom, M., Bergsdorf, N., Wallen, P., Jornvall, H.: Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites, and localize variant differences. Biochemistry 23(16), 3701–3707 (1984)
76. Hayes, M.L., Castellino, J.F.: Carbohydrate of the human plasminogen variants. I. carbohydrate composition, glycopeptide isolation, and characterization. J. Biol. Chem. 254(18), 8768–8771 (1979)
77. Pirie-Shepherd, S.R., Stevens, R.D., Andon, N.L., Enghild, J.J., Pizzo, S.V.: Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2. J. Biol. Chem. 272(11), 7408–7411 (1997)
78. Mori, K., Dwek, R.A., Downing, A.K., Opdenakker, G., Rudd, P.M.: The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator. J. Biol. Chem. 270(7), 3261–3267 (1995)
79. Wittwer, A.J., Howard, S.C., Carr, L.S., Harakas, N.K., Feder, J., Parekh, R.B., Rudd, P.M., Dwek, R.A., Rademacher, T.W.: Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator. Biochemistry 28(19), 7662–7669 (1989)
80. Opdenakker, G., Van Damme, J., Bosman, F., Billiau, A., De Somer, P.: Influence of carbohydrate side chains on activity of tissue-type plasminogen activator. Proc. Soc. Experiment. Biol. Med. Soc. Experiment. Biol. Med. (New York, N.Y.) 182(2), 248–257 (1986)
81. Gonzalez-Gronow, M., Edelberg, J.M., Pizzo, S.V.: Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry 28(6), 2374–2377 (1989)
82. Aisina, R., Mukhametova, L., Gershkovich, K., Varfolomeyev, S.: The role of carbohydrate side chains of plasminogen in its activation by staphylokinase. Biochim. Biophys. Acta 1725(3), 370–376 (2005). doi:10.1016/j.bbagen.2005.07.007
83. Hatton, M.W., Southward, S., Ross-Ouellet, B.: Catabolism of plasminogen glycoforms I and II in rabbits: relationship to plasminogen synthesis by the rabbit liver in vitro. Metab. Clin. Exp. 43(11), 1430–1437 (1994)
84. Bhattacharya, S., Ploplis, V.A., Castellino, F.J.: Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J. Biomed. Biotechnol. 2012, 482096 (2012). doi:10.1155/2012/482096
85. Fox, D., Smulian, A.G.: Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii. Med. Mycol. 39(6), 495–507 (2001)
86. Coleman, J.L., Gebbia, J.A., Piesman, J., Degen, J.L., Bugge, T.H., Benach, J.L.: Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89(7), 1111–1119 (1997)
87. Crowe, J.D., Sievwright, I.K., Auld, G.C., Moore, N.R., Gow, N.A., Booth, N.A.: Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol. Microbiol. 47(6), 1637–1651 (2003)
88. Verhamme, I.M., Panizzi, P.R., Bock, P.E.: Pathogen activators of plasminogen. J. Thrombos. Haemostas.: JTH 13(Suppl 1), S106–114 (2015). doi:10.1111/jth.12939
89. De Oliveira, D.M., Law, R.H., Ly, D., Cook, S.M., Quek, A.J., McArthur, J.D., Whisstock, J.C., Sanderson-Smith, M.L.: Preferential acquisition and activation of plasminogen glycoform II by PAM positive group A streptococcal isolates. Biochemistry 54(25), 3960–3968 (2015). doi:10.1021/acs.biochem.5b00130
90. Maverakis, E., Kim, K., Shimoda, M., Gershwin, M.E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L.R., Lebrilla, C.B.: Glycans in the immune system and the Altered Glycan Theory of Autoimmunity: a critical review. J. Autoimmun. 57, 1–13 (2015). doi:10.1016/j.jaut.2014.12.002
91. Wright, A., Morrison, S.L.: Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol. 15(1), 26–32 (1997). doi:10.1016/s0167-7799(96)10062-7
92. Borel, I.M., Gentile, T., Angelucci, J., Margni, R.A., Binaghi, R.A.: Asymmetrically glycosylated IgG isolated from non-immune human sera. Biochim. Biophys. Acta 990(2), 162–164 (1989)
93. Dunn-Walters, D., Boursier, L., Spencer, J.: Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol. Immunol. 37(3–4), 107–113 (2000)
94. Sabouri, Z., Schofield, P., Horikawa, K., Spierings, E., Kipling, D., Randall, K.L., Langley, D., Roome, B., Vazquez-Lombardi, R., Rouet, R., Hermes, J., Chan, T.D., Brink, R., Dunn-Walters, D.K., Christ, D., Goodnow, C.C.: Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc. Natl. Acad. Sci. U. S. A. 111(25), E2567–2575 (2014). doi:10.1073/pnas.1406974111
95. Zhu, D., McCarthy, H., Ottensmeier, C.H., Johnson, P., Hamblin, T.J., Stevenson, F.K.: Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99(7), 2562–2568 (2002)
96. Kuppers, R.: Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5(4), 251–262 (2005). doi:10.1038/nrc1589
97. Schneider, D., Duhren-von Minden, M., Alkhatib, A., Setz, C., van Bergen, C.A., Benkisser-Petersen, M., Wilhelm, I., Villringer, S., Krysov, S., Packham, G., Zirlik, K., Romer, W., Buske, C., Stevenson, F.K., Veelken, H., Jumaa, H.: Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. Blood 125(21), 3287–3296 (2015). doi:10.1182/blood-2014-11-609404
98. Coelho, V., Krysov, S., Ghaemmaghami, A.M., Emara, M., Potter, K.N., Johnson, P., Packham, G., Martinez-Pomares, L., Stevenson, F.K.: Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc. Natl. Acad. Sci. U. S. A. 107(43), 18587–18592 (2010). doi:10.1073/pnas.1009388107
99. Scott, K., Gadomski, T., Kozicz, T., Morava, E.: Congenital disorders of glycosylation: new defects and still counting. J. Inherit. Metab. Dis. 37(4), 609–617 (2014). doi:10.1007/s10545-014-9720-9
100. Jaeken, J., Hennet, T., Matthijs, G., Freeze, H.H.: CDG nomenclature: time for a change! Biochim. Biophys. Acta 1792(9), 825–826 (2009). doi:10.1016/j.bbadis.2009.08.005
101. Bailey, U.M., Jamaluddin, M.F., Schulz, B.L.: Analysis of congenital disorder of glycosylation-Id in a yeast model system shows diverse site-specific under-glycosylation of glycoproteins. J. Proteome Res. 11(11), 5376–5383 (2012). doi:10.1021/pr300599f
102. Rind, N., Schmeiser, V., Thiel, C., Absmanner, B., Lubbehusen, J., Hocks, J., Apeshiotis, N., Wilichowski, E., Lehle, L., Korner, C.: A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip. Hum. Mol. Genet. 19(8), 1413–1424 (2010). doi:10.1093/hmg/ddq016
103. Weinstein, M., Schollen, E., Matthijs, G., Neupert, C., Hennet, T., Grubenmann, C.E., Frank, C.G., Aebi, M., Clarke, J.T., Griffiths, A., Seargeant, L., Poplawski, N.: CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. Am. J. Med. Genet. A 136(2), 194–197 (2005). doi:10.1002/ajmg.a.30851
104. Katoh, T., Takase, J., Tani, Y., Amamoto, R., Aoshima, N., Tiemeyer, M., Yamamoto, K., Ashida, H.: Deficiency of alpha-glucosidase I alters glycoprotein glycosylation and lifespan in Caenorhabditis elegans. Glycobiology 23(10), 1142–1151 (2013). doi:10.1093/glycob/cwt051
105. Struwe, W.B., Hughes, B.L., Osborn, D.W., Boudreau, E.D., Shaw, K.M., Warren, C.E.: Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci. Glycobiology 19(12), 1554–1562 (2009). doi:10.1093/glycob/cwp136
106. Ishikawa, H.O., Higashi, S., Ayukawa, T., Sasamura, T., Kitagawa, M., Harigaya, K., Aoki, K., Ishida, N., Sanai, Y., Matsuno, K.: Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc. Proc. Natl. Acad. Sci. U. S. A. 102(51), 18532–18537 (2005). doi:10.1073/pnas.0504115102
107. Lehle, L., Strahl, S., Tanner, W.: Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. Angewandte Chemie. (International ed. in English) 45(41), 6802–6818 (2006). doi:10.1002/anie.200601645
108. Hulsmeier, A.J., Paesold-Burda, P., Hennet, T.: N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry. Molec. Cell. Proteom.: MCP 6(12), 2132–2138 (2007). doi:10.1074/mcp.M700361-MCP200
109. Jones, M.A., Ng, B.G., Bhide, S., Chin, E., Rhodenizer, D., He, P., Losfeld, M.E., He, M., Raymond, K., Berry, G., Freeze, H.H., Hegde, M.R.: DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. Am. J. Hum. Genet. 90(2), 363–368 (2012). doi:10.1016/j.ajhg.2011.12.024
110. Shrimal, S., Ng, B.G., Losfeld, M.E., Gilmore, R., Freeze, H.H.: Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum. Mol. Genet. 22(22), 4638–4645 (2013). doi:10.1093/hmg/ddt312
111. Molinari, F., Foulquier, F., Tarpey, P.S., Morelle, W., Boissel, S., Teague, J., Edkins, S., Futreal, P.A., Stratton, M.R., Turner, G., Matthijs, G., Gecz, J., Munnich, A., Colleaux, L.: Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am. J. Hum. Genet. 82(5), 1150–1157 (2008). doi:10.1016/j.ajhg.2008.03.021
112. Lawson, V.A., Collins, S.J., Masters, C.L., Hill, A.F.: Prion protein glycosylation. J. Neurochem. 93(4), 793–801 (2005). doi:10.1111/j.1471-4159.2005.03104.x
113. Bosques, C.J., Imperiali, B.: The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. Proc. Natl. Acad. Sci. U. S. A. 100(13), 7593–7598 (2003)
114. Priola, S.A., Lawson, V.A.: Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J. 20(23), 6692–6699 (2001). doi:10.1093/emboj/20.23.6692
115. Somerville, R.A.: Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J. Gen. Virol. 80(Pt 7), 1865–1872 (1999)
116. Collinge, J., Sidle, K.C., Meads, J., Ironside, J., Hill, A.F.: Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383(6602), 685–690 (1996). doi:10.1038/383685a0
117. Wiseman, F.K., Cancellotti, E., Piccardo, P., Iremonger, K., Boyle, A., Brown, D., Ironside, J.W., Manson, J.C., Diack, A.B.: The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species. J. Virol. 89(9), 4738–4747 (2015). doi:10.1128/jvi.02296-14
118. DeArmond, S.J., Sanchez, H., Yehiely, F., Qiu, Y., Ninchak-Casey, A., Daggett, V., Camerino, A.P., Cayetano, J., Rogers, M., Groth, D., Torchia, M., Tremblay, P., Scott, M.R., Cohen, F.E., Prusiner, S.B.: Selective neuronal targeting in prion disease. Neuron 19(6), 1337–1348 (1997)
119. Salamat, M.K., Dron, M., Chapuis, J., Langevin, C., Laude, H.: Prion propagation in cells expressing PrP glycosylation mutants. J. Virol. 85(7), 3077–3085 (2011). doi:10.1128/jvi.02257-10
120. Brooks, S.A.: Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system. Mol. Biotechnol. 28(3), 241–255 (2004). doi:10.1385/mb:28:3:241
121. Roifman, C.M., Mills, G.B., Chu, M., Gelfand, E.W.: Functional comparison of recombinant interleukin 2 (IL-2) with IL-2-containing preparations derived from cultured cells. Cell. Immunol. 95(1), 146–156 (1985)
122. Dissing-Olesen, L., Thaysen-Andersen, M., Meldgaard, M., Hojrup, P., Finsen, B.: The function of the human interferon-beta 1a glycan determined in vivo. J. Pharmacol. Experiment. Therapeut. 326(1), 338–347 (2008). doi:10.1124/jpet.108.138263
123. Beintema, J.J., Gaastra, W., Scheffer, A.J., Welling, G.W.: Carbohydrate in pancreatic ribonucleases. Europ. J. Biochem. / FEBS 63(2), 441–448 (1976)
124. Hirs, C.H., Moore, S., Stein, W.H.: A chromatographic investigation of pancreatic ribonuclease. J. Biol. Chem. 200(2), 493–506 (1953)
125. Tarentino, A., Plummer Jr., T.H., Maley, F.: Studies on the oligosaccharide sequence of ribonuclease B. J. Biol. Chem. 245(16), 4150–4157 (1970)
126. Krebs, H., Schmid, F.X., Jaenicke, R.: Folding of homologous proteins. the refolding of different ribonucleases is independent of sequence variations, proline content and glycosylation. J. Mol. Biol. 169(2), 619–635 (1983)
127. Rudd, P.M., Joao, H.C., Coghill, E., Fiten, P., Saunders, M.R., Opdenakker, G., Dwek, R.A.: Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 33(1), 17–22 (1994)
128. Baynes, J.W., Wold, F.: Effect of glycosylation on the in vivo circulating half-life of ribonuclease. J. Biol. Chem. 251(19), 6016–6024 (1976)
129. Liu, L.: Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J. Pharm. Sci. 104(6), 1866–1884 (2015). doi:10.1002/jps.24444
130. Tao, M.H., Morrison, S.L.: Studies of aglycosylated chimeric mouse-human IgG. role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. (Baltimore, Md.: 1950) 143(8), 2595–2601 (1989)
131. Ju, M.S., Jung, S.T.: Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics. Curr. Opin. Biotechnol. 30, 128–139 (2014). doi:10.1016/j.copbio.2014.06.013
132. Raju, T.S.: Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC. Methods Molec. Biol. (Clifton, N.J.) 988, 169–180 (2013). doi:10.1007/978-1-62703-327-5_10
133. Jeong, T.H., Son, Y.J., Ryu, H.B., Koo, B.K., Jeong, S.M., Hoang, P., Do, B.H., Song, J.A., Chong, S.H., Robinson, R.C., Choe, H.: Soluble expression and partial purification of recombinant human erythropoietin from E. coli. Protein Expr. Purif. 95, 211–218 (2014). doi:10.1016/j.pep.2014.01.001
134. Elliott, S., Lorenzini, T., Asher, S., Aoki, K., Brankow, D., Buck, L., Busse, L., Chang, D., Fuller, J., Grant, J., Hernday, N., Hokum, M., Hu, S., Knudten, A., Levin, N., Komorowski, R., Martin, F., Navarro, R., Osslund, T., Rogers, G., Rogers, N., Trail, G., Egrie, J.: Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat. Biotechnol. 21(4), 414–421 (2003). doi:10.1038/nbt799
135. Taylor, J.S., Zhang, Q., Julander, J.G., Stoycheva, A.D., Tan, H., Moy, C.V., Chanda, S., Symons, J.A., Beigelman, L.N., Blatt, L.M., Hong, J.: Development of a hyperglycosylated IFN alfacon-1 (CIFN): toward bimonthly or monthly dosing for antiviral therapies. J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res. 35(8), 621–633 (2015). doi:10.1089/jir.2014.0138
136. Piirainen, M.A., de Ruijter, J.C., Koskela, E.V., Frey, A.D.: Glycoengineering of yeasts from the perspective of glycosylation efficiency. New Biotechnol. 31(6), 532–537 (2014). doi:10.1016/j.nbt.2014.03.001
137. Ollis, A.A., Zhang, S., Fisher, A.C., DeLisa, M.P.: Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity. Nat. Chem. Biol. 10(10), 816–822 (2014). doi:10.1038/nchembio.1609
138. Choi, B.K., Warburton, S., Lin, H., Patel, R., Boldogh, I., Meehl, M., d’Anjou, M., Pon, L., Stadheim, T.A., Sethuraman, N.: Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris. Appl. Microbiol. Biotechnol. 95(3), 671–682 (2012). doi:10.1007/s00253-012-4067-3
139. Parsaie Nasab, F., Aebi, M., Bernhard, G., Frey, A.D.: A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 79(3), 997–1007 (2013). doi:10.1128/aem.02817-12
140. Kowarik, M., Young, N.M., Numao, S., Schulz, B.L., Hug, I., Callewaert, N., Mills, D.C., Watson, D.C., Hernandez, M., Kelly, J.F., Wacker, M., Aebi, M.: Definition of the bacterial N-glycosylation site consensus sequence. EMBO J. 25(9), 1957–1966 (2006)
141. Bosch, M., Trombetta, S., Engstrom, U., Parodi, A.J.: Characterization of dolichol diphosphate oligosaccharide: protein oligosaccharyltransferase and glycoprotein-processing glucosidases occurring in trypanosomatid protozoa. J. Biol. Chem. 263(33), 17360–17365 (1988)
142. de la Canal, L., Parodi, A.J.: Synthesis of dolichol derivatives in trypanosomatids. characterization of enzymatic patterns. J. Biol. Chem. 262(23), 11128–11133 (1987)
143. Aebi, M., Gassenhuber, J., Domdey, H., te Heesen, S.: Cloning and characterization of the ALG3 gene of Saccharomyces cerevisiae. Glycobiology 6(4), 439–444 (1996)
144. Ballou, L., Gopal, P., Krummel, B., Tammi, M., Ballou, C.E.: A mutation that prevents glucosylation of the lipid-linked oligosaccharide precursor leads to underglycosylation of secreted yeast invertase. Proc. Natl. Acad. Sci. U. S. A. 83(10), 3081–3085 (1986)
145. Burda, P., Jakob, C.A., Beinhauer, J., Hegemann, J.H., Aebi, M.: Ordered assembly of the asymmetrically branched lipid-linked oligosaccharide in the endoplasmic reticulum is ensured by the substrate specificity of the individual glycosyltransferases. Glycobiology 9(6), 617–625 (1999)
146. De Pourcq, K., Tiels, P., Van Hecke, A., Geysens, S., Vervecken, W., Callewaert, N.: Engineering Yarrowia lipolytica to produce glycoproteins homogeneously modified with the universal Man3GlcNAc2 N-glycan core. PLoS One 7(6), e39976 (2012). doi:10.1371/journal.pone.0039976
147. Olsen, J.V., Mann, M.: Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteomics 12(12), 3444–3452 (2013). doi:10.1074/mcp.O113.034181
148. Xu, Y., Bailey, U.M., Punyadeera, C., Schulz, B.L.: Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and LC-ESI-MS/MS. Rapid Commun. Mass Spectrom. 28(5), 471–482 (2014)
149. Kaji, H., Isobe, T.: Stable isotope labeling of N-Glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics. Methods Mol. Biol. 951, 217–227 (2013). doi:10.1007/978-1-62703-146-2_14
150. Chen, C.C., Su, W.C., Huang, B.Y., Chen, Y.J., Tai, H.C., Obena, R.P.: Interaction modes and approaches to glycopeptide and glycoprotein enrichment. Analyst 139(4), 688–704 (2014). doi:10.1039/c3an01813j
151. Zhang, H., Li, X.J., Martin, D.B., Aebersold, R.: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21(6), 660–666 (2003)
152. Mysling, S., Palmisano, G., Højrup, P., Thaysen-Andersen, M.: Utilizing ion-pairing hydrophilic interaction chromatography solid phase extraction for efficient glycopeptide enrichment in glycoproteomics. Anal. Chem. 82(13), 5598–5609 (2010)
153. Wada, Y., Tajiri, M., Yoshida, S.: Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal. Chem. 76(22), 6560–6565 (2004)
154. Li, Y., Pfüller, U., Larsson, E.L., Jungvid, H., Galaev, I.Y., Mattiasson, B.: Separation of mistletoe lectins based on the degree of glycosylation using boronate affinity chromatography. J. Chromatogr. A 925(1–2), 115–121 (2001)
155. Choi, E., Loo, D., Dennis, J.W., O’Leary, C.A., Hill, M.M.: High-throughput lectin magnetic bead array-coupled tandem mass spectrometry for glycoprotein biomarker discovery. Electrophoresis 32(24), 3564–3575 (2011). doi:10.1002/elps.201100341
156. Wiśniewski, J.R., Zielinska, D.F., Mann, M.: Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by the filter-aided sample preparation method. Anal. Biochem. (2010)
157. Breidenbach, M.A., Palaniappan, K.K., Pitcher, A.A., Bertozzi, C.R.: Mapping yeast N-glycosites with isotopically recoded glycans. Mol. Cell. Proteomics 11(6), M111.015339 (2012). doi:10.1074/mcp.M111.015339
158. Heywood, W.E., Mills, P., Grunewald, S., Worthington, V., Jaeken, J., Carreno, G., Lemonade, H., Clayton, P.T., Mills, K.: A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation. J. Proteome Res. 12(7), 3471–3479 (2013). doi:10.1021/pr400328g
159. Sumer-Bayraktar, Z., Kolarich, D., Campbell, M.P., Ail, S., Packer, N.H., Thaysen-Andersen, M.: N-glycans modulate the function of human corticosteroid-binding globulin. Mol. Cell. Proteomics 10(8), M111.009100 (2011)
160. Holland, J.W., Deeth, H.C., Alewood, P.F.: Analysis of O-glycosylation site occupancy in bovine kappa-casein glycoforms separated by two-dimensional gel electrophoresis. Proteomics 5(4), 990–1002 (2005)
161. Packer, N.H., Lawson, M.A., Jardine, D.R., Sanchez, J.C., Gooley, A.A.: Analyzing glycoproteins separated by two-dimensional gel electrophoresis. Electrophoresis 19(6), 981–988 (1998)
162. Wang, B., Tsybovsky, Y., Palczewski, K., Chance, M.R.: Reliable determination of site-specific in vivo protein N-glycosylation based on collision-induced MS/MS and chromatographic retention time. J. Am. Soc. Mass Spectrom. 25(5), 729–741 (2014). doi:10.1007/s13361-013-0823-6
163. Christiansen, M.N., Kolarich, D., Nevalainen, H., Packer, N.H., Jensen, P.H.: Challenges of determining O-glycopeptide heterogeneity: a fungal glucanase model system. Anal. Chem. 82(9), 3500–3509 (2010)
164. Stavenhagen, K., Hinneburg, H., Thaysen-Andersen, M., Hartmann, L., Varón Silva, D., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P.H., Kolarich, D.: Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J. Mass Spectrom. 48(6), 627–639 (2013). doi:10.1002/jms.3210
165. Xu, Y., Bailey, U.M., Schulz, B.L.: Automated measurement of site-specific N-glycosylation occupancy with SWATH-MS. Proteomics 15(13), 2177–2186 (2015). doi:10.1002/pmic.201400465
166. Palmisano, G., Melo-Braga, M.N., Engholm-Keller, K., Parker, B.L., Larsen, M.R.: Chemical deamidation: a common pitfall in large-scale N-linked glycoproteomic mass spectrometry-based analyses. J. Proteome Res. 11(3), 1949–1957 (2012)
167. Robinson, N.E., Robinson, Z.W., Robinson, B.R., Robinson, A.L., Robinson, J.A., Robinson, M.L., Robinson, A.B.: Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J. Pept. Res. 63(5), 426–436 (2004)
168. Thaysen-Andersen, M., Packer, N.H.: Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology 22(11), 1440–1452 (2012). doi:10.1093/glycob/cws110
169. Segu, Z.M., Hussein, A., Novotny, M.V., Mechref, Y.: Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture. J. Proteome Res. 9(7), 3598–3607 (2010). doi:10.1021/pr100129n
170. Hülsmeier, A.J., Paesold-Burda, P., Hennet, T.: N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography mass spectrometry. Mol. Cell. Proteomics 6(12), 2132–2138 (2007)
171. Sun, Z., Chen, R., Cheng, K., Liu, H., Qin, H., Ye, M., Zou, H.: A new method for quantitative analysis of cell surface glycoproteome. Proteomics 12(22), 3328–3337 (2012). doi:10.1002/pmic.201200150
172. Sun, S., Zhang, H.: Large-scale measurement of absolute protein glycosylation stoichiometry. Anal. Chem. 87(13), 6479–6482 (2015). doi:10.1021/acs.analchem.5b01679
173. Lin, C.Y., C, M.Y., Pai, P.J., Her, G.R.: A comparative study of glycoprotein concentration, glycoform profile and glycosylation site occupancy using isotope labeling and electrospray linear ion trap mass spectrometry. Anal. Chim. Acta 728, 49–56 (2012). doi:10.1016/j.aca.2012.03.058
174. Nettleship, J.E., Aplin, R., Aricescu, A.R., Evans, E.J., Davis, S.J., Crispin, M., Owens, R.J.: Analysis of variable N-glycosylation site occupancy in glycoproteins by liquid chromatography electrospray ionization mass spectrometry. Anal. Biochem. 361(1), 149–151 (2007)
175. Zhu, Z., Go, E.P., Desaire, H.: Absolute quantitation of glycosylation site occupancy using isotopically labeled standards and LC-MS. J. Am. Soc. Mass Spectrom. 25, 1012–1017 (2014)
176. Windwarder, M., Altmann, F.: Site-specific analysis of the O-glycosylation of bovine fetuin by electron-transfer dissociation mass spectrometry. J. Proteomics 108, 258–268 (2014). doi:10.1016/j.jprot.2014.05.022
177. Ali, L., Flowers, S.A., Jin, C., Bennet, E.P., Ekwall, A.K., Karlsson, N.G.: The O-glycomap of lubricin, a novel mucin responsible for joint lubrication, identified by site-specific glycopeptide analysis. Mol. Cell. Proteomics 13(12), 3396–3409 (2014). doi:10.1074/mcp.M114.040865
178. Wada, Y.: Label-free analysis of o-glycosylation site-occupancy based on the signal intensity of glycopeptide/peptide ions. Mass Spectrom. (Tokyo) 1(2), A0008 (2012). doi:10.5702/massspectrometry.A0008
179. Plomp, R., Dekkers, G., Rombouts, Y., Visser, R., Koeleman, C.A., Kammeijer, G.S., Jansen, B.C., Rispens, T., Hensbergen, P.J., Vidarsson, G., Wuhrer, M.: Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3). Mol. Cell. Proteomics 14(5), 1373–1384 (2015). doi:10.1074/mcp.M114.047381
180. Sturiale, L., Barone, R., Palmigiano, A., Ndosimao, C.N., Briones, P., Adamowicz, M., Jaeken, J., Garozzo, D.: Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS. Proteomics 8(18), 3822–3832 (2008)
181. Bergen, H.R., Lacey, J.M., O’Brien, J.F., Naylor, S.: Online single-step analysis of blood proteins: the transferrin story. Anal. Biochem. 296(1), 122–129 (2001)
182. Gault, J., Ferber, M., Machata, S., Imhaus, A.F., Malosse, C., Charles-Orszag, A., Millien, C., Bouvier, G., Bardiaux, B., Pehau-Arnaudet, G., Klinge, K., Podglajen, I., Ploy, M.C., Seifert, H.S., Nilges, M., Chamot-Rooke, J., Dumenil, G.: Neisseria meningitidis type IV pili composed of sequence invariable pilins are masked by multisite glycosylation. PLoS Pathog. 11(9), e1005162 (2015). doi:10.1371/journal.ppat.1005162